Literature DB >> 7918495

Kinetics of the inhibition of factor Xa and the tissue factor-factor VIIa complex by the tissue factor pathway inhibitor in the presence and absence of heparin.

J Jesty1, T C Wun, A Lorenz.   

Abstract

The inhibition by tissue factor pathway inhibitor (TFPI) of its two target enzymes--factor Xa and the tissue factor-factor VIIa complex (TF:VIIa)--has been studied under near-physiological reactant concentrations and conditions. Over a TFPI range of 0-1 nM, the rate of inhibition of factor Xa, in the presence of Ca2+ and anionic phospholipid vesicles at 37 degrees C, was proportional to TFPI concentration, giving an association rate, k1, of 0.96 x 10(9) M-1 min-1. Factor Xa inhibition did not proceed to completion, the reaction attaining a near-equilibrium that was dependent on the TFPI concentration. The estimated dissociation rate of the TFPI:Xa complex, k-1, was independent of TFPI concentration, with a mean value of 0.02 min-1. The resulting calculated value of K1, the apparent dissociation constant for the initial step, is 21 pM. Slow decay of the remaining factor Xa in such incubations, detectable after attainment of the rapid initial near-equilibrium, confirmed the two-step mechanism proposed by Huang et al. (1993) [J. Biol. Chem. 268, 26950-26955], but did not permit determination of a rate constant for the second step. Omission of anionic phospholipid had no significant effect on either k1 or k-1. A high-molecular-weight fraction of heparin, at saturating levels (> or = 0.05 unit/mL, congruent to 25 nM), increased k1 2-fold, with no detectable effect on k-1. The second stage of TFPI action was studied by preformation of the TFPI:Xa complex, and its incubation with the TF:VIIa complex in the presence of factor X.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918495     DOI: 10.1021/bi00208a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow.

Authors:  Karin Leiderman; Aaron L Fogelson
Journal:  Math Med Biol       Date:  2010-05-03       Impact factor: 1.854

2.  Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor.

Authors:  J Franssen; I Salemink; G M Willems; T C Wun; H C Hemker; T Lindhout
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  A Mathematical Model of Venous Thrombosis Initiation.

Authors:  Priscilla Elizondo; Aaron L Fogelson
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

Review 4.  Revisiting the Pharmacology of Unfractionated Heparin.

Authors:  Abdallah Derbalah; Stephen Duffull; Fiona Newall; Katie Moynihan; Hesham Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2019-08       Impact factor: 6.447

5.  The tissue factor requirement in blood coagulation.

Authors:  Thomas Orfeo; Saulius Butenas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  J Biol Chem       Date:  2005-10-07       Impact factor: 5.157

6.  Simulated surface-induced thrombin generation in a flow field.

Authors:  S W Jordan; E L Chaikof
Journal:  Biophys J       Date:  2011-07-20       Impact factor: 4.033

7.  Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.

Authors:  A L Kuharsky; A L Fogelson
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

8.  Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.

Authors:  J D Sipley; D S Alexander; J E Testa; J P Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.

Authors:  P Sen; A A Komissarov; G Florova; S Idell; U R Pendurthi; L Vijaya Mohan Rao
Journal:  J Thromb Haemost       Date:  2011-03       Impact factor: 5.824

10.  A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.

Authors:  Offer Erez; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Francesca Gotsch; Juan Pedro Kusanovic; Nandor Gabor Than; Shali Mazaki-Tovi; Edi Vaisbuch; Zoltan Papp; Bo Hyun Yoon; Yu Mi Han; Debra Hoppensteadt; Jawed Fareed; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.